Royal Dutch Shell Plc  .com Rotating Header Image

Tobacco corporations lobby to hamper passing of EU health laws, say academics

Internal documents reveal impact of tobacco industry

Sarah Boseley Health editor
The Guardian, Tuesday 12 January 2010

Major corporations, led by British American Tobacco, waged a successful lobbying campaign to hamper the passing of public health legislation and weaken its impact, a group of academics claim today.

Proposals to restrict smoking in public were in BAT’s sights in the 1990s but the changes the lobbying brought about to EU policymaking have been fundamental and enduring, say the academics.

They are now being used to undermine legislation designed to protect the public against toxic chemicals, they say.

The strategy is revealed in internal documents that BAT was forced to disclose during litigation on tobacco harm in the US.

Disguised behind respectable consultancies and thinktanks, the companies succeeded in getting a form of impact assessment made mandatory for every EU policy which – critics say – emphasised the financial costs to business and underestimated the impact on public health.

The manoeuvering behind the scenes is revealed in a paper published by researchers from the school of health at Bath University, the Centre for International Public Policy at Edinburgh University and the London School of Hygiene and Tropical Medicine.

Their paper, published today by PLoS (Public Library of Science) Medicine, says that “BAT and its corporate allies have fundamentally altered the way in which all EU policy is made”.

They say it “increases the likelihood that the EU will produce policies that advance the interests of major corporations, including those that produce products damaging to health, rather than in the interests of its citizens”.

The internal documents show that Bat began lobbying for what it called “structured risk assessment” in the mid 1990s.

“Our analysis reveals that BAT saw RA [risk assessment] as a means of precluding the introduction of public smoking restrictions, which it saw as a growing threat in Europe,” says the paper.

“The UK consultancy firm Charles Barker appears to have then been asked to outline the advantages for BAT of embedding RA within UK and European policymaking processes and advised that BAT would need to tread carefully, lobbying through a ‘front’ organisation and enlisting ‘big industry names in support’.”

The chemical and pharmaceutical industries were mentioned as those most likely to have a common interest.

BAT took the advice. It approached a think-tank called the European Policy Centre, whose director had worked with BAT previously. The EPC then formed an organisation called the Risk Assessment Forum and approached companies to join. Among the companies that became members were Shell, Elf Aquitaine, ICI and several pharmaceutical companies, including Bayer, Johnson and Johnson, SmithKline Beecham, Solvay and Zeneca.

The British government was seen as more supportive of business than some others in Europe.

The industry, say critics, has the money to carry out complex risk assessments and their data is hard to challenge.

GUARDIAN ARTICLE

This website and sisters royaldutchshellgroup.com, shellnazihistory.com, royaldutchshell.website, johndonovan.website, and shellnews.net, are owned by John Donovan. There is also a Wikipedia segment.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Comment Rules

  • Please show respect to the opinions of others no matter how seemingly far-fetched.
  • Abusive, foul language, and/or divisive comments may be deleted without notice.
  • Each blog member is allowed limited comments, as displayed above the comment box.
  • Comments must be limited to the number of words displayed above the comment box.
  • Please limit one comment after any comment posted per post.